Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

BACKGROUND: The current standard treatment, at least in Europe, for patients with primarily resectable tumors, consists of surgery followed by adjuvant chemotherapy. But even in this prognostic favourable group, long term survival is disappointing because of high local and distant failure rates. Pos...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Roeder, Falk, Timke, Carmen, Saleh-Ebrahimi, Ladan, Schneider, Lutz, Hackert, Thilo, Hartwig, Werner, Kopp-Schneider, Annette, Hensley, Frank W, Buechler, Markus W, Debus, Juergen, Huber, Peter E, Werner, Jens
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3323416/
https://ncbi.nlm.nih.gov/pubmed/22443802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-112
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items